In a paper published in the September 5 issue of the online, open-access journal PLoS ONE, Drs. Joe Casey and Yves Sauv? found evidence for blindness associated with a gene involved in retinal pH regulation. Their characterization of a mouse model with a targeted disruption of the Slc4a3 gene has revealed a new cause of blindness.
A blood cell known as a troublemaker for triggering the itch and inflammation in allergy attacks, the mast cell, can also calm down the flare-ups, researchers from Stanford University School of Medicine have found.
As children head back to the classroom, Health Canada is reminding parents of the importance of allergy awareness when packing lunches for their children.
Warnings signs such as increased stress could indicate that pregnancy-induced hypertension is reaching life-threatening levels, found Temple University researcher Kathleen Black, DNSc, RNC, the author of a study in the September/October issue of the Journal of Obstetric, Gynecologic, & Neonatal Nursing.
Researchers in Cincinnati and Louisville report that immunosuppressive risks associated with facial transplantation may be lower than thought, possibly making the procedure a safer option for people who have suffered severe facial injuries.
World renowned experts on motor neurone disease will share their work at an international symposium hosted by the University of Edinburgh to enable greater understanding of the condition.
More than 3% of world population is infected with hepatitis C virus (HCV). The outcome of HCV infections is either self recovery or chronic hepatitis, and many of the chronic infections will develop into liver cirrhosis or liver cancer.
Hepatitis C viral infection disease is a worldwide challenge disease, and researchers has been fighting for seeking the effective way to cure this disease. A research group in Japan has found that hepatitis C viral infection can be cleared by liver transplantation.
Multiple sclerosis – MS – is a disease found in one in 700 Americans. It affects women more often than men, and generally begins to show signs between ages 20-40.
Despite a Rs 650 crore market and an annual growth rate of 25 per cent, Homeopathy is often considered a last resort when other treatments had failed, says a new research study.